SCHOTT PHARMA POLYMER
CARTRIDGE PLATFORM
Schott Pharma continues its
collaboration with SHL Medical and
pre-validates the ISO-standardised
polymer cartridge with SHL Medical’s
large-volume autoinjector platform.

The Schott Toppac ® polymer
cartridge is the first in
Schott Pharma’s
polymer product portfolio to
meet both ISO dimensions and
the global RTU standard, Schott
iQ ® . Polymer solutions come into
play when medications have special
requirements, such as low silicone
levels or
deep-temperature storage,
for example.

Schott Pharma and SHL Medical
conducted compatibility studies
that assessed both dimensional as
well as functional fit of the Schott
Toppac ® polymer cartridge with
Maggie ® autoinjector platforms.

The joint assessment confirmed
the full system compatibility. This
includes the 3ml Schott TOPPAC ®
cartridge with Maggie ® 3.0ml and
the 5ml Schott Toppac ® cartridge
with Maggie ® 5.0 ml autoinjector.

The polymer cartridges are
suitable for safely storing and
administering highly sensitive
biologics, including cell and
gene therapies, biosimilars, and
emergency medications.

“Thanks to our collaboration with
SHL Medical, we’ve taken a big step
forward in offering a complete
solution to pharma companies”,
says Andreas Reisse, CEO of
Schott Pharma.

This milestone enables access
to a pre-validated and de-risked
solution for the safe and
convenient administration of
large-volume medications at home,
supporting self-injection for a wide
range of therapies.

CHP PACKER INTERNATIONAL update 03